Top Device Companies

Gen-Probe Sees No Major Operation Changes Despite Acquisitions

Gen-Probe, a leading maker of genetic tests, expects to see nearly $500 million in revenues this year, one in which it acquired two significant companies. Gen-Probe CEO Carl Hull, who took the position in May, says the firm expects to operate as it has done traditionally, despite the expansion. He steered the purchase of Prodesse to give Gen-Probe a line of tests for infectious diseases such as influenza, just after the firm bought Tepnel, a specialist in prenatal diagnosis and transplant tissue-typing. (Click here for more)

“Gen-Probe Finds Opportunities” – San Diego Union-Tribune (11/30/09)

JUST PUBLISHED: Medical Device Market 2009: Interventional Cardiology - Find out who’s going beyond catheters and drug-eluting stents in this vibrant space with this 86-page Special Report previously published in IN VIVO: The Business & Medicine Report. Order yours now!

Deals in Depth: January 2009

Article preview from IN VIVO - March 2009

January 2009 dealmaking highlights: Big Pharma consolidation is back in the news as one of the largest mega-mergers in history took place in January with Pfizer's acquisition of Wyeth for $67bn. Abbott topped the list on the device side, leaping into the vision care field with its $2.8bn purchase of Advanced Medical Optics. Meanwhile financing--mainly from private placements--for both the drug and device industries was up from the previous month, and notably pharma showed a 4x increase in private investor funding.

Gen-Probe Buy Of Tepnel Set To Complete About April 8

Gen-Probe’s acquisition of U.K.-based Tepnel Life Sciences for $132.1 million is expected to become effective about the end of the first week in April, the British company said. Tepnel makes genetic analysis kits and services, which Gen-Probe expects to be a fit for its diagnostics products. The schedule was confirmed after the offer was submitted to Tepnel shareholders. The Gen-Probe purchase offer is for all of the shares of the U.K. firm. (Click here for more)

"Tepnel Says Gen-Probe Offer To Take Effect On April 8" – Reuters (2/23/09)

Get the week's top medical device news sent directly to you. Sign up for the FREE once-a-week email newsletter from Top Device Companies.com

Gen-Probe Adds European Reach Through $132 Million Tepnel Acquisition

Full article reprinted from “The Gray Sheet” - February 9, 2009

Gen-Probe will double its European sales force and expand its existing molecular diagnostics portfolio through the $132.2 million purchase of UK-based Tepnel Life Sciences. Find out more...